Skip to content

Effect of Carbloading and Maltodextrin on the Level of Function in Patients With Apoplexia

Randomized Controlled Trial on the Effect of Carbloading and Maltodextrin on the Level of Function in Patients With Apoplexia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04688489
Acronym
ApoCarb
Enrollment
20
Registered
2020-12-30
Start date
2020-08-01
Completion date
2020-12-01
Last updated
2020-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apoplexy; Brain

Keywords

carbohydrates, rehabilitation, high-carbohydrate diet

Brief summary

The study will investigate the potential effect of a supplement of maltodextrin and added dietary carbohydrates on the level of function in patients with apoplexia. The study has an intervention group and a control group. The study is randomized, but not blinded. The primary outcome is level of function measured with Barthel-100. Besides the primary outcome there are several secondary outcomes (see detailed description). All patients are recruited from Rigshospitalet, Glostrup.

Detailed description

The study will investigate the potential effect of a supplement of maltodextrin (20 g for women and 30 g for men) and added dietary carbohydrates on the level of function in patients with apoplexia. The study has an intervention group and a control group. The study is randomized, but not blinded. The primary outcome is level of function measured with Barthel-100. Secondary outcomes are: training intensity, duration and frequency; length of stay; self-training (training without a therapist) and patient's experienced fatigue; and patient's experienced pain. All patients are recruited from Rigshospitalet, Glostrup. The supplement will be administered before and after each training session with a therapist. The supplement is a powder desolved in a glass of juice. The nursing staff will add extra carbohydrates to the patient's meals in the form of potatoes, rice, bread, fruit or other carbohydrate rich food items. All meals will be noted daily and validated the following day by the primary investigators.

Interventions

DIETARY_SUPPLEMENTCarbloading and maltodextrin

The intervention is a dietary intervention that consists of a supplement of maltodextrin and added dietary carbohydrates. The supplement (20 g for women and 30 g for men) will be given to patients before and after a scheduled training, while the carbohydrates are given with meals. The extra carbohydrates given at meal time consists of extra potatoes, rice, bread, fruit, juice or other carbohydrate-rich food items.

Sponsors

Rigshospitalet, Denmark
CollaboratorOTHER
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with apoplexia who are declared suited for rehabilitation at Afs. Neurologisk Afdeling N 35 - Apopleksi or Afs. Neurologisk Afdeling N 45 - Apopleksi, Rigshospitalet, Glostrup * Patient must be able to consent participation * Age 50+ years * Must be able to understand danish * Must be relevant for physio- or occupational therapy

Exclusion criteria

* Diabetes Mellitus type I og type II * Enteral nutrition (tube feeding) * Barthel-100 over 80 points

Design outcomes

Primary

MeasureTime frameDescription
Difference between inclusion and discharge in score8 weeksMeasured with Barthel100 by the nursing staff

Secondary

MeasureTime frameDescription
Intensity of training (score)8 weeksAssessed by the therapists who trained with the patient.
Duration of training (hours)8 weeksAssessed by the therapists after every training. Noted i the same document as intensity of training
Frequency of training with therapist (episodes/week)8 weeksAssessed by the therapists after every training.
Length of stay (days)8 weeksMeasured in full days
Level of experienced post-work out muscle soreness (VAS - score)8 weeksMeasured by a VAS-pain scale.
Level of physical activity during hospital admission - daily score8 weeksNoted on a document by the patient or the study officials.
Level of experienced fatique (VAS - score)8 weeksMeasured by a VAS-fatigue scale.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026